Literature DB >> 28334953

Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering.

Annie Vogel Ciernia1,2,3, Michael C Pride3,4, Blythe Durbin-Johnson5, Adriana Noronha1,2,3, Alene Chang1,2,3, Dag H Yasui1,2,3,4, Jacqueline N Crawley3,4, Janine M LaSalle1,2,3,4,6.   

Abstract

Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the gene encoding methyl CpG binding protein 2 (MeCP2) that occur sporadically in 1:10,000 female births. RTT is characterized by a period of largely normal development followed by regression in language and motor skills at 6-18 months of age. Mecp2 mutant mice recapitulate many of the clinical features of RTT, but the majority of behavioral assessments have been conducted in male Mecp2 hemizygous null mice as offspring of heterozygous dams. Given that RTT patients are predominantly female, we conducted a systematic analysis of developmental milestones, sensory abilities, and motor deficits, following the longitudinal decline of function from early postnatal to adult ages in female Mecp2 heterozygotes of the conventional Bird line (Mecp2tm1.1bird-/+), as compared to their female wildtype littermate controls. Further, we assessed the impact of postnatal maternal environment on developmental milestones and behavioral phenotypes. Cross-fostering to CD1 dams accelerated several developmental milestones independent of genotype, and induced earlier onset of weight gain in adult female Mecp2tm1.1bird-/+ mice. Cross-fostering improved the sensitivity of a number of motor behaviors that resulted in observable deficits in Mecp2tm1.1bird-/+ mice at much earlier (6-7 weeks) ages than were previously reported (6-9 months). Our findings indicate that female Mecp2tm1.1bird-/+ mice recapitulate many of the motor aspects of RTT syndrome earlier than previously appreciated. In addition, rearing conditions may impact the phenotypic severity and improve the ability to detect genotype differences in female Mecp2 mutant mice.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28334953      PMCID: PMC6075042          DOI: 10.1093/hmg/ddx087

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  86 in total

1.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  MeCP2 mutations in children with and without the phenotype of Rett syndrome.

Authors:  K Hoffbuhr; J M Devaney; B LaFleur; N Sirianni; C Scacheri; J Giron; J Schuette; J Innis; M Marino; M Philippart; V Narayanan; R Umansky; D Kronn; E P Hoffman; S Naidu
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

3.  HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner.

Authors:  Jakob Haettig; Daniel P Stefanko; Monica L Multani; Dario X Figueroa; Susan C McQuown; Marcelo A Wood
Journal:  Learn Mem       Date:  2011-01-11       Impact factor: 2.460

4.  Mecp2 truncation in male mice promotes affiliative social behavior.

Authors:  B L Pearson; E B Defensor; R L H Pobbe; L H L Yamamoto; V J Bolivar; D C Blanchard; R J Blanchard
Journal:  Behav Genet       Date:  2011-09-11       Impact factor: 2.805

5.  Rett syndrome: long-term clinical follow-up experiences over four decades.

Authors:  Bengt Hagberg
Journal:  J Child Neurol       Date:  2005-09       Impact factor: 1.987

6.  Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.

Authors:  Saurabh K Garg; Daniel T Lioy; Hélène Cheval; James C McGann; John M Bissonnette; Matthew J Murtha; Kevin D Foust; Brian K Kaspar; Adrian Bird; Gail Mandel
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

7.  Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome.

Authors:  Nupur Nag; Joanne E Berger-Sweeney
Journal:  Neurobiol Dis       Date:  2007-02-13       Impact factor: 5.996

8.  Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.

Authors:  Tatiana M Kazdoba; Randi J Hagerman; Dorota Zolkowska; Michael A Rogawski; Jacqueline N Crawley
Journal:  Psychopharmacology (Berl)       Date:  2015-11-03       Impact factor: 4.530

9.  Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.

Authors:  Paolo Moretti; J Adriaan Bouwknecht; Ryan Teague; Richard Paylor; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2004-11-17       Impact factor: 6.150

Review 10.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more
  16 in total

1.  MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.

Authors:  Annie Vogel Ciernia; Dag H Yasui; Michael C Pride; Blythe Durbin-Johnson; Adriana B Noronha; Alene Chang; Trina A Knotts; Jennifer R Rutkowsky; Jon J Ramsey; Jacqueline N Crawley; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

Review 2.  Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.

Authors:  Anna Adhikari; Nycole A Copping; Beth Onaga; Michael C Pride; Rochelle L Coulson; Mu Yang; Dag H Yasui; Janine M LaSalle; Jill L Silverman
Journal:  Neurobiol Learn Mem       Date:  2018-05-23       Impact factor: 2.877

3.  Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.

Authors:  P T Leach; J N Crawley
Journal:  Genes Brain Behav       Date:  2018-02-15       Impact factor: 3.449

4.  Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.

Authors:  Mayara C Ribeiro; Jessica L MacDonald
Journal:  Neurobiol Dis       Date:  2022-01-25       Impact factor: 5.996

5.  Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.

Authors:  Lieselot L G Carrette; Roy Blum; Weiyuan Ma; Raymond J Kelleher; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

Review 6.  Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development.

Authors:  Mayara C Ribeiro; Jessica L MacDonald
Journal:  Brain Res       Date:  2020-01-02       Impact factor: 3.252

7.  Motor, Somatosensory, Viscerosensory and Metabolic Impairments in a Heterozygous Female Rat Model of Rett Syndrome.

Authors:  Aritra Bhattacherjee; Michelle K Winter; Linda S Eggimann; Ying Mu; Sumedha Gunewardena; Zhaohui Liao; Julie A Christianson; Peter G Smith
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

8.  Deletion of a non-canonical regulatory sequence causes loss of Scn1a expression and epileptic phenotypes in mice.

Authors:  Jessica L Haigh; Anna Adhikari; Nycole A Copping; Tyler Stradleigh; A Ayanna Wade; Rinaldo Catta-Preta; Linda Su-Feher; Iva Zdilar; Sarah Morse; Timothy A Fenton; Anh Nguyen; Diana Quintero; Samrawit Agezew; Michael Sramek; Ellie J Kreun; Jasmine Carter; Andrea Gompers; Jason T Lambert; Cesar P Canales; Len A Pennacchio; Axel Visel; Diane E Dickel; Jill L Silverman; Alex S Nord
Journal:  Genome Med       Date:  2021-04-26       Impact factor: 11.117

9.  Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in Mecp2 Mutant Mice.

Authors:  Mayara C Ribeiro; Seth M Moore; Noriyuki Kishi; Jeffrey D Macklis; Jessica L MacDonald
Journal:  eNeuro       Date:  2020-05-22

10.  Protective role of mirtazapine in adult female Mecp2+/- mice and patients with Rett syndrome.

Authors:  Javier Flores Gutiérrez; Claudio De Felice; Giulia Natali; Silvia Leoncini; Cinzia Signorini; Joussef Hayek; Enrico Tongiorgi
Journal:  J Neurodev Disord       Date:  2020-09-28       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.